Profilo
Mishima S.
Gerhart worked as Head-Regulatory Affairs at Genzyme Corp.
from 2014 to 2016.
From 2014 to 2020, served as Vice President & Head-Regulatory Affairs at Sanofi.
Held the position of Chief Regulatory Officer & Head-Quality at Taysha Gene Therapies, Inc. Also worked as Chief Regulatory Officer at Pliant Therapeutics, Inc. Completed undergraduate studies at Kutztown University of Pennsylvania and graduate studies at Temple University (Pennsylvania).
Precedenti posizioni note di Mishima Gerhart
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Consigliere Generale | 01/06/2020 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Consigliere Generale | 01/01/2016 |
| PLIANT THERAPEUTICS, INC. | Consigliere Generale | - |
| TAYSHA GENE THERAPIES, INC. | Consigliere Generale | - |
Formazione di Mishima Gerhart
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Kutztown University of Pennsylvania
Kutztown University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
















